Trinity Biotech Advances Premier Hb9210 Rollout and HIV Test Outsourcing
Trinity Biotech reports continued progress in its transformation strategy, including rollout of its next-generation high-capacity Premier Hb9210™ upgraded column system, now completed in three major international markets with positive customer feedback. The company also transitioned significant portions of manufacturing for its WHO-approved rapid HIV tests to an outsourced model, completing ~9 million TrinScreen tests and starting Uni-Gold™ production, while appointing Romero to strengthen its commercial organization.